The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Biopharmaceutical Testing Services-Global Market Insights and Sales Trends 2025
Synopsis
The global Biopharmaceutical Testing Services market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Biopharmaceutical Testing Services in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Biopharmaceutical Testing Services market. Raw Materials Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the In-Process and Product Release Testing segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biopharmaceutical Testing Services, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biopharmaceutical Testing Services market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biopharmaceutical Testing Services market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biopharmaceutical Testing Services sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biopharmaceutical Testing Services covered in this report include Eurofins Scientific, SGS, Envigo, Exova Group, PPD Inc., Pace Analytical Services, Intertek Group, DYNALABS and RD Laboratories, etc.
The global Biopharmaceutical Testing Services market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eurofins Scientific
SGS
Envigo
Exova Group
PPD Inc.
Pace Analytical Services
Intertek Group
DYNALABS
RD Laboratories
West Pharmaceutical Services
Polymer Solutions
Boston Analytical
Accuratus Labs
Microbac
ARLBioPharma
Lapuck Laboratories
BioScreen
Global Biopharmaceutical Testing Services market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biopharmaceutical Testing Services market, Segment by Type:
Raw Materials Testing
In-Process and Product Release Testing
Finished Pharmaceutical Products Testing
Environmental Samples
Others
Global Biopharmaceutical Testing Services market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biopharmaceutical Testing Services companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Biopharmaceutical Testing Services market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Biopharmaceutical Testing Services in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Biopharmaceutical Testing Services market. Raw Materials Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the In-Process and Product Release Testing segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biopharmaceutical Testing Services, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biopharmaceutical Testing Services market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biopharmaceutical Testing Services market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biopharmaceutical Testing Services sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biopharmaceutical Testing Services covered in this report include Eurofins Scientific, SGS, Envigo, Exova Group, PPD Inc., Pace Analytical Services, Intertek Group, DYNALABS and RD Laboratories, etc.
The global Biopharmaceutical Testing Services market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eurofins Scientific
SGS
Envigo
Exova Group
PPD Inc.
Pace Analytical Services
Intertek Group
DYNALABS
RD Laboratories
West Pharmaceutical Services
Polymer Solutions
Boston Analytical
Accuratus Labs
Microbac
ARLBioPharma
Lapuck Laboratories
BioScreen
Global Biopharmaceutical Testing Services market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biopharmaceutical Testing Services market, Segment by Type:
Raw Materials Testing
In-Process and Product Release Testing
Finished Pharmaceutical Products Testing
Environmental Samples
Others
Global Biopharmaceutical Testing Services market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biopharmaceutical Testing Services companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Biopharmaceutical Testing Services
1.1 Biopharmaceutical Testing Services Market Overview
1.1.1 Biopharmaceutical Testing Services Product Scope
1.1.2 Biopharmaceutical Testing Services Market Status and Outlook
1.2 Global Biopharmaceutical Testing Services Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Biopharmaceutical Testing Services Market Size by Region (2018-2029)
1.4 Global Biopharmaceutical Testing Services Historic Market Size by Region (2018-2023)
1.5 Global Biopharmaceutical Testing Services Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Biopharmaceutical Testing Services Market Size (2018-2029)
1.6.1 North America Biopharmaceutical Testing Services Market Size (2018-2029)
1.6.2 Europe Biopharmaceutical Testing Services Market Size (2018-2029)
1.6.3 Asia-Pacific Biopharmaceutical Testing Services Market Size (2018-2029)
1.6.4 Latin America Biopharmaceutical Testing Services Market Size (2018-2029)
1.6.5 Middle East & Africa Biopharmaceutical Testing Services Market Size (2018-2029)
2 Biopharmaceutical Testing Services Market by Type
2.1 Introduction
2.1.1 Raw Materials Testing
2.1.2 In-Process and Product Release Testing
2.1.3 Finished Pharmaceutical Products Testing
2.1.4 Environmental Samples
2.1.5 Others
2.2 Global Biopharmaceutical Testing Services Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Biopharmaceutical Testing Services Historic Market Size by Type (2018-2023)
2.2.2 Global Biopharmaceutical Testing Services Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Biopharmaceutical Testing Services Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Biopharmaceutical Testing Services Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Biopharmaceutical Testing Services Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Biopharmaceutical Testing Services Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Biopharmaceutical Testing Services Revenue Breakdown by Type (2018-2029)
3 Biopharmaceutical Testing Services Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Biopharmaceutical Testing Services Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Biopharmaceutical Testing Services Historic Market Size by Application (2018-2023)
3.2.2 Global Biopharmaceutical Testing Services Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Biopharmaceutical Testing Services Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Biopharmaceutical Testing Services Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Biopharmaceutical Testing Services Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Biopharmaceutical Testing Services Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Biopharmaceutical Testing Services Revenue Breakdown by Application (2018-2029)
4 Biopharmaceutical Testing Services Competition Analysis by Players
4.1 Global Biopharmaceutical Testing Services Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biopharmaceutical Testing Services as of 2022)
4.3 Date of Key Players Enter into Biopharmaceutical Testing Services Market
4.4 Global Top Players Biopharmaceutical Testing Services Headquarters and Area Served
4.5 Key Players Biopharmaceutical Testing Services Product Solution and Service
4.6 Competitive Status
4.6.1 Biopharmaceutical Testing Services Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Eurofins Scientific
5.1.1 Eurofins Scientific Profile
5.1.2 Eurofins Scientific Main Business
5.1.3 Eurofins Scientific Biopharmaceutical Testing Services Products, Services and Solutions
5.1.4 Eurofins Scientific Biopharmaceutical Testing Services Revenue (US$ Million) & (2018-2023)
5.1.5 Eurofins Scientific Recent Developments
5.2 SGS
5.2.1 SGS Profile
5.2.2 SGS Main Business
5.2.3 SGS Biopharmaceutical Testing Services Products, Services and Solutions
5.2.4 SGS Biopharmaceutical Testing Services Revenue (US$ Million) & (2018-2023)
5.2.5 SGS Recent Developments
5.3 Envigo
5.3.1 Envigo Profile
5.3.2 Envigo Main Business
5.3.3 Envigo Biopharmaceutical Testing Services Products, Services and Solutions
5.3.4 Envigo Biopharmaceutical Testing Services Revenue (US$ Million) & (2018-2023)
5.3.5 Exova Group Recent Developments
5.4 Exova Group
5.4.1 Exova Group Profile
5.4.2 Exova Group Main Business
5.4.3 Exova Group Biopharmaceutical Testing Services Products, Services and Solutions
5.4.4 Exova Group Biopharmaceutical Testing Services Revenue (US$ Million) & (2018-2023)
5.4.5 Exova Group Recent Developments
5.5 PPD Inc.
5.5.1 PPD Inc. Profile
5.5.2 PPD Inc. Main Business
5.5.3 PPD Inc. Biopharmaceutical Testing Services Products, Services and Solutions
5.5.4 PPD Inc. Biopharmaceutical Testing Services Revenue (US$ Million) & (2018-2023)
5.5.5 PPD Inc. Recent Developments
5.6 Pace Analytical Services
5.6.1 Pace Analytical Services Profile
5.6.2 Pace Analytical Services Main Business
5.6.3 Pace Analytical Services Biopharmaceutical Testing Services Products, Services and Solutions
5.6.4 Pace Analytical Services Biopharmaceutical Testing Services Revenue (US$ Million) & (2018-2023)
5.6.5 Pace Analytical Services Recent Developments
5.7 Intertek Group
5.7.1 Intertek Group Profile
5.7.2 Intertek Group Main Business
5.7.3 Intertek Group Biopharmaceutical Testing Services Products, Services and Solutions
5.7.4 Intertek Group Biopharmaceutical Testing Services Revenue (US$ Million) & (2018-2023)
5.7.5 Intertek Group Recent Developments
5.8 DYNALABS
5.8.1 DYNALABS Profile
5.8.2 DYNALABS Main Business
5.8.3 DYNALABS Biopharmaceutical Testing Services Products, Services and Solutions
5.8.4 DYNALABS Biopharmaceutical Testing Services Revenue (US$ Million) & (2018-2023)
5.8.5 DYNALABS Recent Developments
5.9 RD Laboratories
5.9.1 RD Laboratories Profile
5.9.2 RD Laboratories Main Business
5.9.3 RD Laboratories Biopharmaceutical Testing Services Products, Services and Solutions
5.9.4 RD Laboratories Biopharmaceutical Testing Services Revenue (US$ Million) & (2018-2023)
5.9.5 RD Laboratories Recent Developments
5.10 West Pharmaceutical Services
5.10.1 West Pharmaceutical Services Profile
5.10.2 West Pharmaceutical Services Main Business
5.10.3 West Pharmaceutical Services Biopharmaceutical Testing Services Products, Services and Solutions
5.10.4 West Pharmaceutical Services Biopharmaceutical Testing Services Revenue (US$ Million) & (2018-2023)
5.10.5 West Pharmaceutical Services Recent Developments
5.11 Polymer Solutions
5.11.1 Polymer Solutions Profile
5.11.2 Polymer Solutions Main Business
5.11.3 Polymer Solutions Biopharmaceutical Testing Services Products, Services and Solutions
5.11.4 Polymer Solutions Biopharmaceutical Testing Services Revenue (US$ Million) & (2018-2023)
5.11.5 Polymer Solutions Recent Developments
5.12 Boston Analytical
5.12.1 Boston Analytical Profile
5.12.2 Boston Analytical Main Business
5.12.3 Boston Analytical Biopharmaceutical Testing Services Products, Services and Solutions
5.12.4 Boston Analytical Biopharmaceutical Testing Services Revenue (US$ Million) & (2018-2023)
5.12.5 Boston Analytical Recent Developments
5.13 Accuratus Labs
5.13.1 Accuratus Labs Profile
5.13.2 Accuratus Labs Main Business
5.13.3 Accuratus Labs Biopharmaceutical Testing Services Products, Services and Solutions
5.13.4 Accuratus Labs Biopharmaceutical Testing Services Revenue (US$ Million) & (2018-2023)
5.13.5 Accuratus Labs Recent Developments
5.14 Microbac
5.14.1 Microbac Profile
5.14.2 Microbac Main Business
5.14.3 Microbac Biopharmaceutical Testing Services Products, Services and Solutions
5.14.4 Microbac Biopharmaceutical Testing Services Revenue (US$ Million) & (2018-2023)
5.14.5 Microbac Recent Developments
5.15 ARLBioPharma
5.15.1 ARLBioPharma Profile
5.15.2 ARLBioPharma Main Business
5.15.3 ARLBioPharma Biopharmaceutical Testing Services Products, Services and Solutions
5.15.4 ARLBioPharma Biopharmaceutical Testing Services Revenue (US$ Million) & (2018-2023)
5.15.5 ARLBioPharma Recent Developments
5.16 Lapuck Laboratories
5.16.1 Lapuck Laboratories Profile
5.16.2 Lapuck Laboratories Main Business
5.16.3 Lapuck Laboratories Biopharmaceutical Testing Services Products, Services and Solutions
5.16.4 Lapuck Laboratories Biopharmaceutical Testing Services Revenue (US$ Million) & (2018-2023)
5.16.5 Lapuck Laboratories Recent Developments
5.17 BioScreen
5.17.1 BioScreen Profile
5.17.2 BioScreen Main Business
5.17.3 BioScreen Biopharmaceutical Testing Services Products, Services and Solutions
5.17.4 BioScreen Biopharmaceutical Testing Services Revenue (US$ Million) & (2018-2023)
5.17.5 BioScreen Recent Developments
6 North America
6.1 North America Biopharmaceutical Testing Services Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Biopharmaceutical Testing Services Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical Testing Services Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Biopharmaceutical Testing Services Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical Testing Services Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Biopharmaceutical Testing Services Market Dynamics
11.1 Biopharmaceutical Testing Services Industry Trends
11.2 Biopharmaceutical Testing Services Market Drivers
11.3 Biopharmaceutical Testing Services Market Challenges
11.4 Biopharmaceutical Testing Services Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
